Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
出版年份 2011 全文链接
标题
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 152, Issue 5, Pages 579-592
出版商
Wiley
发表日期
2011-01-18
DOI
10.1111/j.1365-2141.2010.08533.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacokinetic and Pharmacodynamic Modeling of an Anti-Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
- (2010) T. Puchalski et al. CLINICAL CANCER RESEARCH
- Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death
- (2009) Peter M. Voorhees et al. BRITISH JOURNAL OF HAEMATOLOGY
- A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
- (2009) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- Growth suppressive cytokines and the AKT/mTOR pathway
- (2009) Barbara Kroczynska et al. CYTOKINE
- Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
- (2009) Cyrille Hulin et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy
- (2009) M. Condomines et al. JOURNAL OF IMMUNOLOGY
- The use of novel agents in the treatment of relapsed and refractory multiple myeloma
- (2009) J P Laubach et al. LEUKEMIA
- Proteasome inhibitors in the treatment of multiple myeloma
- (2009) J J Shah et al. LEUKEMIA
- Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- (2008) Deborah J. Kuhn et al. BLOOD
- The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma
- (2008) Philipp Baumann et al. EXPERIMENTAL CELL RESEARCH
- Treatment of plasma cell dyscrasias with lenalidomide
- (2008) M A Dimopoulos et al. LEUKEMIA
- Treatment of newly diagnosed myeloma
- (2008) A Palumbo et al. LEUKEMIA
- Commitment in apoptosis: slightly dead but mostly alive
- (2008) Clare Sheridan et al. TRENDS IN CELL BIOLOGY
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
- (2008) Jerry E. Chipuk et al. TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now